US_Oncol_A&S.qxp 27/11/08 04:44 Page 2
US Oncology
Established: January 2005 Current Edition: Volume 4
Formerly US Oncological Disease
Aims and Scope
• US Oncology enables time-pressured physicians to stay abreast of key advances and opinion in oncological practice in the US.
• US Oncology comprises balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments
in the field of oncology.
• US Oncology endeavors to support physicians, clinicians, and leading industry professionals in continuously developing their knowledge, effectiveness,
and productivity. The editorial policy has been designed to encourage discussion among this peer group.
• Comprehensive bibliographies for each article mean that US Oncology is an informative and valuable reference tool for use throughout the year.
Structure and Format
• US Oncology is an annual journal comprising review articles, case reports, practice guides, theoretical discussions, and original research.
• The structure of each edition of the publication comprises section categories determined by the Editor. The degree of coverage assigned to each
category is the decision of the Editor, and in part reflects the views of the Advisory Panel.
• Articles are fully referenced, providing a comprehensive review of existing knowledge and opinion.
• Each edition of US Oncology is also replicated in full online at
www.touchbriefings.com
Editorial Expertise
US Oncology is supported by various levels of expertise:
• Guidance from an Advisory Panel consisting of leading authorities from a variety of oncological disciplines.
• Invited contributors are recognized authorities from their respective fields.
• Peer review—conducted by experts appointed for their experience and knowledge of a specific topic.
• An experienced team of Editors and Technical Editors.
Peer Review
• On submission, all articles are assessed by the Editor to determine their suitability for inclusion and appropriateness for peer review.
• The Editor, following consultation with either a member of the Advisory Panel or the author, identifies appropriate reviewers, who are selected on the
basis of their specialist knowledge in the relevant area.
• Following review, papers are either accepted without modification or returned to the author to incorporate required changes. The Editor reserves the
right to accept or reject any proposed amendments.
Submissions and Instructions to Authors
• Contributors are identified and invited by the Editor with the support of the Technical Editors and guidance from the Advisory Panel.
• Following acceptance of an invitation, the author and Editor formalize the working title and scope of the article.
• Subsequently, the Editor provides an ‘Instruction to Authors’ document and additional submission details.
• The Editor is always keen to hear from leading authorities wishing to discuss potential submissions, and will give due consideration to any proposals.
Please contact the Editor for further details. The ‘Instruction to Authors’ information is available for download at
www.touchbriefings.com
Reprints
All articles included in US Oncology are available as reprints (minimum order 1,000).
Please contact Tim Green at
tim.green@touchbriefings.com or T: +44 (0) 20 7452 5023.
Distribution and Readership
• US Oncology is distributed annually through controlled circulation to senior professionals in the oncology field in the US.
• US Oncology is audited by BPA Worldwide.
Copyright and Permission
Touch Briefings, a Touch Group plc company, is the sole owner of all articles and other materials that appear in US Oncology, unless otherwise stated.
Permission to reproduce an article, either in full or in part, should be sought from the publication’s Editor.
www.touchbriefings.com
•
www.touchbriefings.com provides clinicians and other industry professionals with a free resource of thousands of articles from approximately 50 annual
and bi-annual publications, spanning 22 healthcare specialties.
• Available online at
www.touchbriefings.com is US Oncology’s sister publication, European Oncology.
About Touch Briefings
Touch Briefings publishes a rich and diverse portfolio of fully referenced review journals across the clinical and pharmaceutical arenas. Through this
portfolio of approximately 50 print publications and dedicated industry websites, Touch Briefings aims to assist in the education and practice of healthcare
and pharmaceutical professionals. ■
2 © TOUCH BRIEFINGS 2008
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84